Evaluation of the Clinical Effect in the Treatment of Acute Cerebral Infarctions with ShiJieYin(GM_1)

DING Su-ju,WANG Xin,Sun Xian-jiang,WANG Ge-ying,WEI Wen-Shi,LIU Xue-yuan,MIAO Ling,WANG Gen-Fa
DOI: https://doi.org/10.3969/j.issn.1008-0678.2005.03.016
2005-01-01
Abstract:Aim:To evaluate the clinical curative effect and safety of ganglioside GM1 in treatment of acute cerebral infarctions. Methods:96 patients from the onset within 72 h were randomly divided into two groups:the ganglioside GM1 treated group and control group. The Chinese Stroke Scale (CSS),Barthel Index (BI) ,and Rankin Scale were used to evaluate the recovery of neurological functions.Results:The obvious effective rate of the therapy group was 52.08%,response rate was 31.25%. Whereas,these data of the control group were 25.00% and 52.08%,respectively.The Barthel Index significantly changed in treatment group(P0.05) . Rankin Scale at 3 months after initiation significantly decreased in treatment group. Conclusion:Ganglioside GM1 is effective and relative safety in treatment of acute cerebral infarctions.
What problem does this paper attempt to address?